nodes	percent_of_prediction	percent_of_DWPC	metapath
Nabumetone—Nonsteroidal Anti-inflammatory Compounds—Acetylsalicylic acid—coronary artery disease	0.394	1	CiPCiCtD
Nabumetone—rheumatoid arthritis—Acetylsalicylic acid—coronary artery disease	0.137	0.588	CpDpCtD
Nabumetone—MPO—coronary artery disease	0.123	0.727	CbGaD
Nabumetone—osteoarthritis—Acetylsalicylic acid—coronary artery disease	0.096	0.412	CpDpCtD
Nabumetone—PTGS2—coronary artery disease	0.0462	0.273	CbGaD
Nabumetone—PTGS2—Acetylsalicylic acid—coronary artery disease	0.0243	0.291	CbGbCtD
Nabumetone—PTGS1—Acetylsalicylic acid—coronary artery disease	0.0206	0.246	CbGbCtD
Nabumetone—CYP1A2—Gemfibrozil—coronary artery disease	0.0169	0.202	CbGbCtD
Nabumetone—CYP1A2—Clopidogrel—coronary artery disease	0.0146	0.175	CbGbCtD
Nabumetone—CYP1A2—Losartan—coronary artery disease	0.00714	0.0855	CbGbCtD
Nabumetone—Melatonin—CALR—coronary artery disease	0.000793	0.616	CrCbGaD
Nabumetone—MPO—artery—coronary artery disease	0.000664	0.153	CbGeAlD
Nabumetone—MPO—endothelium—coronary artery disease	0.000561	0.129	CbGeAlD
Nabumetone—MPO—myocardium—coronary artery disease	0.00035	0.0806	CbGeAlD
Nabumetone—PTGS1—artery—coronary artery disease	0.000315	0.0725	CbGeAlD
Nabumetone—PTGS2—artery—coronary artery disease	0.000301	0.0693	CbGeAlD
Nabumetone—PTGS1—endothelium—coronary artery disease	0.000266	0.0612	CbGeAlD
Nabumetone—PTGS2—endothelium—coronary artery disease	0.000254	0.0585	CbGeAlD
Nabumetone—MPO—heart—coronary artery disease	0.000244	0.0563	CbGeAlD
Nabumetone—MPO—cardiovascular system—coronary artery disease	0.000231	0.0531	CbGeAlD
Nabumetone—MPO—blood—coronary artery disease	0.000182	0.042	CbGeAlD
Nabumetone—PTGS1—myocardium—coronary artery disease	0.000166	0.0383	CbGeAlD
Nabumetone—Melatonin—MPO—coronary artery disease	0.000156	0.121	CrCbGaD
Nabumetone—Melatonin—ESR1—coronary artery disease	0.000117	0.0907	CrCbGaD
Nabumetone—PTGS1—heart—coronary artery disease	0.000116	0.0267	CbGeAlD
Nabumetone—PTGS2—heart—coronary artery disease	0.000111	0.0255	CbGeAlD
Nabumetone—PTGS1—cardiovascular system—coronary artery disease	0.000109	0.0252	CbGeAlD
Nabumetone—PTGS2—cardiovascular system—coronary artery disease	0.000105	0.0241	CbGeAlD
Nabumetone—CYP1A2—blood—coronary artery disease	9.99e-05	0.023	CbGeAlD
Nabumetone—PTGS1—cardiac atrium—coronary artery disease	9.92e-05	0.0228	CbGeAlD
Nabumetone—Melatonin—CYP2C19—coronary artery disease	9.38e-05	0.0728	CrCbGaD
Nabumetone—PTGS1—blood—coronary artery disease	8.65e-05	0.0199	CbGeAlD
Nabumetone—PTGS2—blood—coronary artery disease	8.27e-05	0.019	CbGeAlD
Nabumetone—Naproxen—PTGS2—coronary artery disease	6.78e-05	0.0527	CrCbGaD
Nabumetone—Naproxen—ALB—coronary artery disease	6.04e-05	0.0469	CrCbGaD
Nabumetone—Rash—Lovastatin—coronary artery disease	2.9e-05	0.000359	CcSEcCtD
Nabumetone—Dermatitis—Lovastatin—coronary artery disease	2.9e-05	0.000359	CcSEcCtD
Nabumetone—Anaemia—Lisinopril—coronary artery disease	2.9e-05	0.000359	CcSEcCtD
Nabumetone—Dyspepsia—Losartan—coronary artery disease	2.89e-05	0.000358	CcSEcCtD
Nabumetone—Feeling abnormal—Perindopril—coronary artery disease	2.89e-05	0.000358	CcSEcCtD
Nabumetone—Headache—Lovastatin—coronary artery disease	2.88e-05	0.000357	CcSEcCtD
Nabumetone—Pruritus—Valsartan—coronary artery disease	2.88e-05	0.000356	CcSEcCtD
Nabumetone—Dry mouth—Ramipril—coronary artery disease	2.88e-05	0.000356	CcSEcCtD
Nabumetone—Vomiting—Ezetimibe—coronary artery disease	2.87e-05	0.000355	CcSEcCtD
Nabumetone—Hypersensitivity—Pravastatin—coronary artery disease	2.87e-05	0.000355	CcSEcCtD
Nabumetone—Gastrointestinal pain—Perindopril—coronary artery disease	2.87e-05	0.000355	CcSEcCtD
Nabumetone—Anxiety—Timolol—coronary artery disease	2.87e-05	0.000355	CcSEcCtD
Nabumetone—Angioedema—Lisinopril—coronary artery disease	2.86e-05	0.000354	CcSEcCtD
Nabumetone—Pruritus—Olmesartan—coronary artery disease	2.86e-05	0.000354	CcSEcCtD
Nabumetone—Decreased appetite—Losartan—coronary artery disease	2.86e-05	0.000354	CcSEcCtD
Nabumetone—Abdominal pain—Captopril—coronary artery disease	2.85e-05	0.000353	CcSEcCtD
Nabumetone—Body temperature increased—Captopril—coronary artery disease	2.85e-05	0.000353	CcSEcCtD
Nabumetone—Dizziness—Simvastatin—coronary artery disease	2.85e-05	0.000352	CcSEcCtD
Nabumetone—Rash—Ezetimibe—coronary artery disease	2.85e-05	0.000352	CcSEcCtD
Nabumetone—Dermatitis—Ezetimibe—coronary artery disease	2.84e-05	0.000352	CcSEcCtD
Nabumetone—Confusional state—Ramipril—coronary artery disease	2.84e-05	0.000352	CcSEcCtD
Nabumetone—Discomfort—Timolol—coronary artery disease	2.84e-05	0.000352	CcSEcCtD
Nabumetone—Asthenia—Niacin—coronary artery disease	2.84e-05	0.000351	CcSEcCtD
Nabumetone—Fatigue—Losartan—coronary artery disease	2.83e-05	0.000351	CcSEcCtD
Nabumetone—Headache—Ezetimibe—coronary artery disease	2.83e-05	0.00035	CcSEcCtD
Nabumetone—Malaise—Lisinopril—coronary artery disease	2.83e-05	0.00035	CcSEcCtD
Nabumetone—Anaphylactic shock—Ramipril—coronary artery disease	2.82e-05	0.000349	CcSEcCtD
Nabumetone—Oedema—Ramipril—coronary artery disease	2.82e-05	0.000349	CcSEcCtD
Nabumetone—Vertigo—Lisinopril—coronary artery disease	2.81e-05	0.000349	CcSEcCtD
Nabumetone—Dry mouth—Timolol—coronary artery disease	2.81e-05	0.000348	CcSEcCtD
Nabumetone—Constipation—Losartan—coronary artery disease	2.81e-05	0.000348	CcSEcCtD
Nabumetone—Syncope—Lisinopril—coronary artery disease	2.81e-05	0.000348	CcSEcCtD
Nabumetone—Vomiting—Eplerenone—coronary artery disease	2.81e-05	0.000348	CcSEcCtD
Nabumetone—Feeling abnormal—Furosemide—coronary artery disease	2.81e-05	0.000348	CcSEcCtD
Nabumetone—Leukopenia—Lisinopril—coronary artery disease	2.8e-05	0.000347	CcSEcCtD
Nabumetone—Nausea—Fenofibrate—coronary artery disease	2.8e-05	0.000347	CcSEcCtD
Nabumetone—Pruritus—Niacin—coronary artery disease	2.8e-05	0.000346	CcSEcCtD
Nabumetone—Asthenia—Pravastatin—coronary artery disease	2.79e-05	0.000346	CcSEcCtD
Nabumetone—Gastrointestinal pain—Furosemide—coronary artery disease	2.79e-05	0.000345	CcSEcCtD
Nabumetone—Rash—Eplerenone—coronary artery disease	2.79e-05	0.000345	CcSEcCtD
Nabumetone—Urticaria—Perindopril—coronary artery disease	2.78e-05	0.000345	CcSEcCtD
Nabumetone—Hypersensitivity—Trandolapril—coronary artery disease	2.78e-05	0.000345	CcSEcCtD
Nabumetone—Dermatitis—Eplerenone—coronary artery disease	2.78e-05	0.000345	CcSEcCtD
Nabumetone—Diarrhoea—Valsartan—coronary artery disease	2.78e-05	0.000344	CcSEcCtD
Nabumetone—Confusional state—Timolol—coronary artery disease	2.78e-05	0.000344	CcSEcCtD
Nabumetone—Shock—Ramipril—coronary artery disease	2.77e-05	0.000343	CcSEcCtD
Nabumetone—Hypersensitivity—Enalapril—coronary artery disease	2.77e-05	0.000343	CcSEcCtD
Nabumetone—Abdominal pain—Perindopril—coronary artery disease	2.77e-05	0.000343	CcSEcCtD
Nabumetone—Body temperature increased—Perindopril—coronary artery disease	2.77e-05	0.000343	CcSEcCtD
Nabumetone—Palpitations—Lisinopril—coronary artery disease	2.77e-05	0.000343	CcSEcCtD
Nabumetone—Diarrhoea—Olmesartan—coronary artery disease	2.77e-05	0.000343	CcSEcCtD
Nabumetone—Headache—Eplerenone—coronary artery disease	2.77e-05	0.000343	CcSEcCtD
Nabumetone—Thrombocytopenia—Ramipril—coronary artery disease	2.76e-05	0.000342	CcSEcCtD
Nabumetone—Anaphylactic shock—Timolol—coronary artery disease	2.76e-05	0.000341	CcSEcCtD
Nabumetone—Oedema—Timolol—coronary artery disease	2.76e-05	0.000341	CcSEcCtD
Nabumetone—Pruritus—Pravastatin—coronary artery disease	2.75e-05	0.000341	CcSEcCtD
Nabumetone—Loss of consciousness—Lisinopril—coronary artery disease	2.75e-05	0.000341	CcSEcCtD
Nabumetone—Nausea—Clopidogrel—coronary artery disease	2.75e-05	0.000341	CcSEcCtD
Nabumetone—Vomiting—Simvastatin—coronary artery disease	2.74e-05	0.000339	CcSEcCtD
Nabumetone—Hypersensitivity—Telmisartan—coronary artery disease	2.74e-05	0.000339	CcSEcCtD
Nabumetone—Cough—Lisinopril—coronary artery disease	2.73e-05	0.000339	CcSEcCtD
Nabumetone—Nausea—Lovastatin—coronary artery disease	2.73e-05	0.000339	CcSEcCtD
Nabumetone—Hyperhidrosis—Ramipril—coronary artery disease	2.73e-05	0.000337	CcSEcCtD
Nabumetone—Rash—Simvastatin—coronary artery disease	2.71e-05	0.000336	CcSEcCtD
Nabumetone—Dermatitis—Simvastatin—coronary artery disease	2.71e-05	0.000336	CcSEcCtD
Nabumetone—Asthenia—Trandolapril—coronary artery disease	2.71e-05	0.000336	CcSEcCtD
Nabumetone—Shock—Timolol—coronary artery disease	2.71e-05	0.000336	CcSEcCtD
Nabumetone—Feeling abnormal—Losartan—coronary artery disease	2.71e-05	0.000335	CcSEcCtD
Nabumetone—Urticaria—Furosemide—coronary artery disease	2.71e-05	0.000335	CcSEcCtD
Nabumetone—Diarrhoea—Niacin—coronary artery disease	2.7e-05	0.000335	CcSEcCtD
Nabumetone—Asthenia—Enalapril—coronary artery disease	2.7e-05	0.000334	CcSEcCtD
Nabumetone—Headache—Simvastatin—coronary artery disease	2.7e-05	0.000334	CcSEcCtD
Nabumetone—Body temperature increased—Furosemide—coronary artery disease	2.69e-05	0.000334	CcSEcCtD
Nabumetone—Abdominal pain—Furosemide—coronary artery disease	2.69e-05	0.000334	CcSEcCtD
Nabumetone—Gastrointestinal pain—Losartan—coronary artery disease	2.69e-05	0.000333	CcSEcCtD
Nabumetone—Dizziness—Valsartan—coronary artery disease	2.69e-05	0.000333	CcSEcCtD
Nabumetone—Anorexia—Ramipril—coronary artery disease	2.69e-05	0.000333	CcSEcCtD
Nabumetone—Nausea—Ezetimibe—coronary artery disease	2.68e-05	0.000332	CcSEcCtD
Nabumetone—Dizziness—Olmesartan—coronary artery disease	2.68e-05	0.000331	CcSEcCtD
Nabumetone—Pruritus—Trandolapril—coronary artery disease	2.67e-05	0.000331	CcSEcCtD
Nabumetone—Hyperhidrosis—Timolol—coronary artery disease	2.66e-05	0.00033	CcSEcCtD
Nabumetone—Asthenia—Telmisartan—coronary artery disease	2.66e-05	0.00033	CcSEcCtD
Nabumetone—Pruritus—Enalapril—coronary artery disease	2.66e-05	0.00033	CcSEcCtD
Nabumetone—Diarrhoea—Pravastatin—coronary artery disease	2.66e-05	0.00033	CcSEcCtD
Nabumetone—Anxiety—Lisinopril—coronary artery disease	2.66e-05	0.000329	CcSEcCtD
Nabumetone—Discomfort—Lisinopril—coronary artery disease	2.64e-05	0.000326	CcSEcCtD
Nabumetone—Anorexia—Timolol—coronary artery disease	2.63e-05	0.000325	CcSEcCtD
Nabumetone—Pruritus—Telmisartan—coronary artery disease	2.63e-05	0.000325	CcSEcCtD
Nabumetone—Nausea—Eplerenone—coronary artery disease	2.62e-05	0.000325	CcSEcCtD
Nabumetone—Dizziness—Niacin—coronary artery disease	2.61e-05	0.000324	CcSEcCtD
Nabumetone—Urticaria—Losartan—coronary artery disease	2.61e-05	0.000323	CcSEcCtD
Nabumetone—Dry mouth—Lisinopril—coronary artery disease	2.61e-05	0.000323	CcSEcCtD
Nabumetone—Abdominal pain—Losartan—coronary artery disease	2.6e-05	0.000322	CcSEcCtD
Nabumetone—Body temperature increased—Losartan—coronary artery disease	2.6e-05	0.000322	CcSEcCtD
Nabumetone—Asthenia—Captopril—coronary artery disease	2.59e-05	0.000321	CcSEcCtD
Nabumetone—Diarrhoea—Trandolapril—coronary artery disease	2.59e-05	0.00032	CcSEcCtD
Nabumetone—Vomiting—Valsartan—coronary artery disease	2.59e-05	0.00032	CcSEcCtD
Nabumetone—Confusional state—Lisinopril—coronary artery disease	2.58e-05	0.000319	CcSEcCtD
Nabumetone—Diarrhoea—Enalapril—coronary artery disease	2.58e-05	0.000319	CcSEcCtD
Nabumetone—Dizziness—Pravastatin—coronary artery disease	2.57e-05	0.000319	CcSEcCtD
Nabumetone—Vomiting—Olmesartan—coronary artery disease	2.57e-05	0.000319	CcSEcCtD
Nabumetone—Rash—Valsartan—coronary artery disease	2.56e-05	0.000317	CcSEcCtD
Nabumetone—Dermatitis—Valsartan—coronary artery disease	2.56e-05	0.000317	CcSEcCtD
Nabumetone—Nausea—Simvastatin—coronary artery disease	2.56e-05	0.000317	CcSEcCtD
Nabumetone—Anaphylactic shock—Lisinopril—coronary artery disease	2.56e-05	0.000317	CcSEcCtD
Nabumetone—Oedema—Lisinopril—coronary artery disease	2.56e-05	0.000317	CcSEcCtD
Nabumetone—Pruritus—Captopril—coronary artery disease	2.55e-05	0.000316	CcSEcCtD
Nabumetone—Rash—Olmesartan—coronary artery disease	2.55e-05	0.000316	CcSEcCtD
Nabumetone—Insomnia—Ramipril—coronary artery disease	2.55e-05	0.000316	CcSEcCtD
Nabumetone—Dermatitis—Olmesartan—coronary artery disease	2.55e-05	0.000316	CcSEcCtD
Nabumetone—Headache—Valsartan—coronary artery disease	2.55e-05	0.000315	CcSEcCtD
Nabumetone—Diarrhoea—Telmisartan—coronary artery disease	2.54e-05	0.000315	CcSEcCtD
Nabumetone—Headache—Olmesartan—coronary artery disease	2.53e-05	0.000314	CcSEcCtD
Nabumetone—Paraesthesia—Ramipril—coronary artery disease	2.53e-05	0.000313	CcSEcCtD
Nabumetone—Shock—Lisinopril—coronary artery disease	2.52e-05	0.000311	CcSEcCtD
Nabumetone—Asthenia—Perindopril—coronary artery disease	2.52e-05	0.000311	CcSEcCtD
Nabumetone—Dyspnoea—Ramipril—coronary artery disease	2.51e-05	0.000311	CcSEcCtD
Nabumetone—Vomiting—Niacin—coronary artery disease	2.51e-05	0.000311	CcSEcCtD
Nabumetone—Hypersensitivity—Furosemide—coronary artery disease	2.51e-05	0.000311	CcSEcCtD
Nabumetone—Somnolence—Ramipril—coronary artery disease	2.51e-05	0.00031	CcSEcCtD
Nabumetone—Thrombocytopenia—Lisinopril—coronary artery disease	2.5e-05	0.00031	CcSEcCtD
Nabumetone—Dizziness—Trandolapril—coronary artery disease	2.5e-05	0.000309	CcSEcCtD
Nabumetone—Insomnia—Timolol—coronary artery disease	2.49e-05	0.000309	CcSEcCtD
Nabumetone—Rash—Niacin—coronary artery disease	2.49e-05	0.000309	CcSEcCtD
Nabumetone—Dermatitis—Niacin—coronary artery disease	2.49e-05	0.000308	CcSEcCtD
Nabumetone—Dizziness—Enalapril—coronary artery disease	2.49e-05	0.000308	CcSEcCtD
Nabumetone—Dyspepsia—Ramipril—coronary artery disease	2.48e-05	0.000307	CcSEcCtD
Nabumetone—Pruritus—Perindopril—coronary artery disease	2.48e-05	0.000307	CcSEcCtD
Nabumetone—Headache—Niacin—coronary artery disease	2.48e-05	0.000307	CcSEcCtD
Nabumetone—Paraesthesia—Timolol—coronary artery disease	2.48e-05	0.000306	CcSEcCtD
Nabumetone—Vomiting—Pravastatin—coronary artery disease	2.47e-05	0.000306	CcSEcCtD
Nabumetone—Hyperhidrosis—Lisinopril—coronary artery disease	2.47e-05	0.000306	CcSEcCtD
Nabumetone—Diarrhoea—Captopril—coronary artery disease	2.47e-05	0.000306	CcSEcCtD
Nabumetone—Dyspnoea—Timolol—coronary artery disease	2.46e-05	0.000304	CcSEcCtD
Nabumetone—Dizziness—Telmisartan—coronary artery disease	2.46e-05	0.000304	CcSEcCtD
Nabumetone—Rash—Pravastatin—coronary artery disease	2.45e-05	0.000304	CcSEcCtD
Nabumetone—Dermatitis—Pravastatin—coronary artery disease	2.45e-05	0.000304	CcSEcCtD
Nabumetone—Decreased appetite—Ramipril—coronary artery disease	2.45e-05	0.000303	CcSEcCtD
Nabumetone—Somnolence—Timolol—coronary artery disease	2.45e-05	0.000303	CcSEcCtD
Nabumetone—Asthenia—Furosemide—coronary artery disease	2.45e-05	0.000303	CcSEcCtD
Nabumetone—Headache—Pravastatin—coronary artery disease	2.44e-05	0.000302	CcSEcCtD
Nabumetone—Anorexia—Lisinopril—coronary artery disease	2.44e-05	0.000302	CcSEcCtD
Nabumetone—Fatigue—Ramipril—coronary artery disease	2.43e-05	0.000301	CcSEcCtD
Nabumetone—Dyspepsia—Timolol—coronary artery disease	2.43e-05	0.0003	CcSEcCtD
Nabumetone—Hypersensitivity—Losartan—coronary artery disease	2.42e-05	0.0003	CcSEcCtD
Nabumetone—Nausea—Valsartan—coronary artery disease	2.41e-05	0.000299	CcSEcCtD
Nabumetone—Pruritus—Furosemide—coronary artery disease	2.41e-05	0.000299	CcSEcCtD
Nabumetone—Constipation—Ramipril—coronary artery disease	2.41e-05	0.000299	CcSEcCtD
Nabumetone—Nausea—Olmesartan—coronary artery disease	2.4e-05	0.000298	CcSEcCtD
Nabumetone—Vomiting—Trandolapril—coronary artery disease	2.4e-05	0.000298	CcSEcCtD
Nabumetone—Diarrhoea—Perindopril—coronary artery disease	2.4e-05	0.000297	CcSEcCtD
Nabumetone—Decreased appetite—Timolol—coronary artery disease	2.4e-05	0.000297	CcSEcCtD
Nabumetone—Vomiting—Enalapril—coronary artery disease	2.39e-05	0.000296	CcSEcCtD
Nabumetone—Dizziness—Captopril—coronary artery disease	2.39e-05	0.000296	CcSEcCtD
Nabumetone—Rash—Trandolapril—coronary artery disease	2.38e-05	0.000295	CcSEcCtD
Nabumetone—Dermatitis—Trandolapril—coronary artery disease	2.38e-05	0.000295	CcSEcCtD
Nabumetone—Fatigue—Timolol—coronary artery disease	2.38e-05	0.000294	CcSEcCtD
Nabumetone—Rash—Enalapril—coronary artery disease	2.37e-05	0.000294	CcSEcCtD
Nabumetone—Dermatitis—Enalapril—coronary artery disease	2.37e-05	0.000294	CcSEcCtD
Nabumetone—Headache—Trandolapril—coronary artery disease	2.37e-05	0.000293	CcSEcCtD
Nabumetone—Vomiting—Telmisartan—coronary artery disease	2.36e-05	0.000292	CcSEcCtD
Nabumetone—Asthenia—Losartan—coronary artery disease	2.36e-05	0.000292	CcSEcCtD
Nabumetone—Headache—Enalapril—coronary artery disease	2.36e-05	0.000292	CcSEcCtD
Nabumetone—Nausea—Niacin—coronary artery disease	2.35e-05	0.000291	CcSEcCtD
Nabumetone—Rash—Telmisartan—coronary artery disease	2.34e-05	0.00029	CcSEcCtD
Nabumetone—Dermatitis—Telmisartan—coronary artery disease	2.34e-05	0.00029	CcSEcCtD
Nabumetone—Diarrhoea—Furosemide—coronary artery disease	2.33e-05	0.000289	CcSEcCtD
Nabumetone—Pruritus—Losartan—coronary artery disease	2.33e-05	0.000288	CcSEcCtD
Nabumetone—Headache—Telmisartan—coronary artery disease	2.33e-05	0.000288	CcSEcCtD
Nabumetone—Feeling abnormal—Ramipril—coronary artery disease	2.32e-05	0.000288	CcSEcCtD
Nabumetone—Dizziness—Perindopril—coronary artery disease	2.32e-05	0.000287	CcSEcCtD
Nabumetone—Insomnia—Lisinopril—coronary artery disease	2.31e-05	0.000286	CcSEcCtD
Nabumetone—Nausea—Pravastatin—coronary artery disease	2.31e-05	0.000286	CcSEcCtD
Nabumetone—Gastrointestinal pain—Ramipril—coronary artery disease	2.31e-05	0.000285	CcSEcCtD
Nabumetone—Paraesthesia—Lisinopril—coronary artery disease	2.3e-05	0.000284	CcSEcCtD
Nabumetone—Vomiting—Captopril—coronary artery disease	2.3e-05	0.000284	CcSEcCtD
Nabumetone—Dyspnoea—Lisinopril—coronary artery disease	2.28e-05	0.000282	CcSEcCtD
Nabumetone—Rash—Captopril—coronary artery disease	2.28e-05	0.000282	CcSEcCtD
Nabumetone—Dermatitis—Captopril—coronary artery disease	2.27e-05	0.000282	CcSEcCtD
Nabumetone—Somnolence—Lisinopril—coronary artery disease	2.27e-05	0.000281	CcSEcCtD
Nabumetone—Feeling abnormal—Timolol—coronary artery disease	2.27e-05	0.000281	CcSEcCtD
Nabumetone—Headache—Captopril—coronary artery disease	2.26e-05	0.00028	CcSEcCtD
Nabumetone—Gastrointestinal pain—Timolol—coronary artery disease	2.25e-05	0.000279	CcSEcCtD
Nabumetone—Dizziness—Furosemide—coronary artery disease	2.25e-05	0.000279	CcSEcCtD
Nabumetone—Dyspepsia—Lisinopril—coronary artery disease	2.25e-05	0.000279	CcSEcCtD
Nabumetone—Diarrhoea—Losartan—coronary artery disease	2.25e-05	0.000279	CcSEcCtD
Nabumetone—Nausea—Trandolapril—coronary artery disease	2.25e-05	0.000278	CcSEcCtD
Nabumetone—Urticaria—Ramipril—coronary artery disease	2.24e-05	0.000277	CcSEcCtD
Nabumetone—Nausea—Enalapril—coronary artery disease	2.24e-05	0.000277	CcSEcCtD
Nabumetone—Vomiting—Perindopril—coronary artery disease	2.23e-05	0.000276	CcSEcCtD
Nabumetone—Body temperature increased—Ramipril—coronary artery disease	2.23e-05	0.000276	CcSEcCtD
Nabumetone—Abdominal pain—Ramipril—coronary artery disease	2.23e-05	0.000276	CcSEcCtD
Nabumetone—Decreased appetite—Lisinopril—coronary artery disease	2.22e-05	0.000275	CcSEcCtD
Nabumetone—Rash—Perindopril—coronary artery disease	2.21e-05	0.000274	CcSEcCtD
Nabumetone—Dermatitis—Perindopril—coronary artery disease	2.21e-05	0.000273	CcSEcCtD
Nabumetone—Nausea—Telmisartan—coronary artery disease	2.21e-05	0.000273	CcSEcCtD
Nabumetone—Fatigue—Lisinopril—coronary artery disease	2.2e-05	0.000273	CcSEcCtD
Nabumetone—Headache—Perindopril—coronary artery disease	2.2e-05	0.000272	CcSEcCtD
Nabumetone—Urticaria—Timolol—coronary artery disease	2.19e-05	0.000271	CcSEcCtD
Nabumetone—Constipation—Lisinopril—coronary artery disease	2.19e-05	0.000271	CcSEcCtD
Nabumetone—Abdominal pain—Timolol—coronary artery disease	2.18e-05	0.00027	CcSEcCtD
Nabumetone—Body temperature increased—Timolol—coronary artery disease	2.18e-05	0.00027	CcSEcCtD
Nabumetone—Dizziness—Losartan—coronary artery disease	2.17e-05	0.000269	CcSEcCtD
Nabumetone—Vomiting—Furosemide—coronary artery disease	2.17e-05	0.000268	CcSEcCtD
Nabumetone—Rash—Furosemide—coronary artery disease	2.15e-05	0.000266	CcSEcCtD
Nabumetone—Dermatitis—Furosemide—coronary artery disease	2.15e-05	0.000266	CcSEcCtD
Nabumetone—Nausea—Captopril—coronary artery disease	2.14e-05	0.000266	CcSEcCtD
Nabumetone—Headache—Furosemide—coronary artery disease	2.13e-05	0.000264	CcSEcCtD
Nabumetone—Feeling abnormal—Lisinopril—coronary artery disease	2.11e-05	0.000261	CcSEcCtD
Nabumetone—Gastrointestinal pain—Lisinopril—coronary artery disease	2.09e-05	0.000259	CcSEcCtD
Nabumetone—Vomiting—Losartan—coronary artery disease	2.09e-05	0.000259	CcSEcCtD
Nabumetone—Nausea—Perindopril—coronary artery disease	2.08e-05	0.000258	CcSEcCtD
Nabumetone—Hypersensitivity—Ramipril—coronary artery disease	2.08e-05	0.000257	CcSEcCtD
Nabumetone—Rash—Losartan—coronary artery disease	2.07e-05	0.000257	CcSEcCtD
Nabumetone—Dermatitis—Losartan—coronary artery disease	2.07e-05	0.000256	CcSEcCtD
Nabumetone—Headache—Losartan—coronary artery disease	2.06e-05	0.000255	CcSEcCtD
Nabumetone—Urticaria—Lisinopril—coronary artery disease	2.03e-05	0.000252	CcSEcCtD
Nabumetone—Hypersensitivity—Timolol—coronary artery disease	2.03e-05	0.000251	CcSEcCtD
Nabumetone—Nausea—Furosemide—coronary artery disease	2.02e-05	0.000251	CcSEcCtD
Nabumetone—Asthenia—Ramipril—coronary artery disease	2.02e-05	0.00025	CcSEcCtD
Nabumetone—Body temperature increased—Lisinopril—coronary artery disease	2.02e-05	0.00025	CcSEcCtD
Nabumetone—Abdominal pain—Lisinopril—coronary artery disease	2.02e-05	0.00025	CcSEcCtD
Nabumetone—Pruritus—Ramipril—coronary artery disease	1.99e-05	0.000247	CcSEcCtD
Nabumetone—Asthenia—Timolol—coronary artery disease	1.98e-05	0.000245	CcSEcCtD
Nabumetone—Nausea—Losartan—coronary artery disease	1.95e-05	0.000242	CcSEcCtD
Nabumetone—Pruritus—Timolol—coronary artery disease	1.95e-05	0.000241	CcSEcCtD
Nabumetone—Diarrhoea—Ramipril—coronary artery disease	1.93e-05	0.000239	CcSEcCtD
Nabumetone—Diarrhoea—Timolol—coronary artery disease	1.89e-05	0.000234	CcSEcCtD
Nabumetone—Hypersensitivity—Lisinopril—coronary artery disease	1.88e-05	0.000233	CcSEcCtD
Nabumetone—Dizziness—Ramipril—coronary artery disease	1.86e-05	0.000231	CcSEcCtD
Nabumetone—Asthenia—Lisinopril—coronary artery disease	1.83e-05	0.000227	CcSEcCtD
Nabumetone—Dizziness—Timolol—coronary artery disease	1.82e-05	0.000226	CcSEcCtD
Nabumetone—Pruritus—Lisinopril—coronary artery disease	1.81e-05	0.000224	CcSEcCtD
Nabumetone—Vomiting—Ramipril—coronary artery disease	1.79e-05	0.000222	CcSEcCtD
Nabumetone—Rash—Ramipril—coronary artery disease	1.78e-05	0.00022	CcSEcCtD
Nabumetone—Dermatitis—Ramipril—coronary artery disease	1.78e-05	0.00022	CcSEcCtD
Nabumetone—Headache—Ramipril—coronary artery disease	1.77e-05	0.000219	CcSEcCtD
Nabumetone—Vomiting—Timolol—coronary artery disease	1.75e-05	0.000217	CcSEcCtD
Nabumetone—Diarrhoea—Lisinopril—coronary artery disease	1.75e-05	0.000217	CcSEcCtD
Nabumetone—Rash—Timolol—coronary artery disease	1.74e-05	0.000215	CcSEcCtD
Nabumetone—Dermatitis—Timolol—coronary artery disease	1.74e-05	0.000215	CcSEcCtD
Nabumetone—Headache—Timolol—coronary artery disease	1.73e-05	0.000214	CcSEcCtD
Nabumetone—Dizziness—Lisinopril—coronary artery disease	1.69e-05	0.000209	CcSEcCtD
Nabumetone—Nausea—Ramipril—coronary artery disease	1.67e-05	0.000207	CcSEcCtD
Nabumetone—Nausea—Timolol—coronary artery disease	1.64e-05	0.000203	CcSEcCtD
Nabumetone—Vomiting—Lisinopril—coronary artery disease	1.63e-05	0.000201	CcSEcCtD
Nabumetone—Rash—Lisinopril—coronary artery disease	1.61e-05	0.0002	CcSEcCtD
Nabumetone—Dermatitis—Lisinopril—coronary artery disease	1.61e-05	0.000199	CcSEcCtD
Nabumetone—Headache—Lisinopril—coronary artery disease	1.6e-05	0.000198	CcSEcCtD
Nabumetone—Nausea—Lisinopril—coronary artery disease	1.52e-05	0.000188	CcSEcCtD
Nabumetone—PTGS1—Metabolism—HBA1—coronary artery disease	5.34e-06	0.000163	CbGpPWpGaD
Nabumetone—PTGS1—Metabolism—CYP2C19—coronary artery disease	5.34e-06	0.000163	CbGpPWpGaD
Nabumetone—PTGS1—Metabolism—PIK3C2A—coronary artery disease	5.34e-06	0.000163	CbGpPWpGaD
Nabumetone—PTGS2—Disease—DCN—coronary artery disease	5.34e-06	0.000163	CbGpPWpGaD
Nabumetone—PTGS2—Metabolism—LPA—coronary artery disease	5.33e-06	0.000163	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism of lipids and lipoproteins—LDLR—coronary artery disease	5.32e-06	0.000162	CbGpPWpGaD
Nabumetone—PTGS1—Metabolism—APOC3—coronary artery disease	5.31e-06	0.000162	CbGpPWpGaD
Nabumetone—PTGS1—Metabolism—LDLR—coronary artery disease	5.27e-06	0.000161	CbGpPWpGaD
Nabumetone—PTGS1—Metabolism of lipids and lipoproteins—POMC—coronary artery disease	5.27e-06	0.00016	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism—GCH1—coronary artery disease	5.26e-06	0.00016	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism—AK1—coronary artery disease	5.26e-06	0.00016	CbGpPWpGaD
Nabumetone—PTGS1—Metabolism—GSTT1—coronary artery disease	5.21e-06	0.000159	CbGpPWpGaD
Nabumetone—PTGS1—Metabolism—SLC9A1—coronary artery disease	5.21e-06	0.000159	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism of lipids and lipoproteins—CETP—coronary artery disease	5.2e-06	0.000158	CbGpPWpGaD
Nabumetone—PTGS2—Metabolism—PLCB3—coronary artery disease	5.17e-06	0.000157	CbGpPWpGaD
Nabumetone—PTGS1—Metabolism—GCLC—coronary artery disease	5.15e-06	0.000157	CbGpPWpGaD
Nabumetone—PTGS1—Metabolism—CETP—coronary artery disease	5.15e-06	0.000157	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism of lipids and lipoproteins—SDC1—coronary artery disease	5.14e-06	0.000157	CbGpPWpGaD
Nabumetone—PTGS2—Metabolism—APOA5—coronary artery disease	5.11e-06	0.000156	CbGpPWpGaD
Nabumetone—PTGS1—Metabolism—SDC1—coronary artery disease	5.09e-06	0.000155	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism—PPAT—coronary artery disease	5.04e-06	0.000154	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism—MDH2—coronary artery disease	5.04e-06	0.000154	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism—UGCG—coronary artery disease	5.04e-06	0.000154	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism—PLCD1—coronary artery disease	5.04e-06	0.000154	CbGpPWpGaD
Nabumetone—PTGS2—Disease—APOC3—coronary artery disease	5.03e-06	0.000153	CbGpPWpGaD
Nabumetone—PTGS2—Metabolism—P4HB—coronary artery disease	5.02e-06	0.000153	CbGpPWpGaD
Nabumetone—PTGS2—Disease—LDLR—coronary artery disease	5e-06	0.000152	CbGpPWpGaD
Nabumetone—PTGS2—Metabolism of lipids and lipoproteins—AGT—coronary artery disease	4.97e-06	0.000151	CbGpPWpGaD
Nabumetone—PTGS2—Disease—SLC9A1—coronary artery disease	4.94e-06	0.00015	CbGpPWpGaD
Nabumetone—PTGS2—Metabolism—PLA2G1B—coronary artery disease	4.92e-06	0.00015	CbGpPWpGaD
Nabumetone—PTGS2—Integrated Pancreatic Cancer Pathway—PIK3CA—coronary artery disease	4.91e-06	0.00015	CbGpPWpGaD
Nabumetone—PTGS2—Metabolism of lipids and lipoproteins—APOE—coronary artery disease	4.87e-06	0.000148	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism—PGM1—coronary artery disease	4.85e-06	0.000148	CbGpPWpGaD
Nabumetone—PTGS2—Disease—SDC1—coronary artery disease	4.83e-06	0.000147	CbGpPWpGaD
Nabumetone—PTGS2—Metabolism of lipids and lipoproteins—APOA1—coronary artery disease	4.81e-06	0.000147	CbGpPWpGaD
Nabumetone—PTGS1—Metabolism—PSMA6—coronary artery disease	4.81e-06	0.000147	CbGpPWpGaD
Nabumetone—PTGS1—Metabolism—PSMB5—coronary artery disease	4.81e-06	0.000147	CbGpPWpGaD
Nabumetone—PTGS1—Metabolism of lipids and lipoproteins—ALB—coronary artery disease	4.8e-06	0.000146	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism of lipids and lipoproteins—CTGF—coronary artery disease	4.74e-06	0.000144	CbGpPWpGaD
Nabumetone—PTGS1—Metabolism—CTGF—coronary artery disease	4.7e-06	0.000143	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism of lipids and lipoproteins—HMGCR—coronary artery disease	4.7e-06	0.000143	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism—PYGB—coronary artery disease	4.68e-06	0.000143	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism—CKB—coronary artery disease	4.68e-06	0.000143	CbGpPWpGaD
Nabumetone—PTGS1—Metabolism—HMGCR—coronary artery disease	4.66e-06	0.000142	CbGpPWpGaD
Nabumetone—PTGS1—Metabolism—GOT2—coronary artery disease	4.66e-06	0.000142	CbGpPWpGaD
Nabumetone—PTGS2—Metabolism—VCAN—coronary artery disease	4.64e-06	0.000141	CbGpPWpGaD
Nabumetone—PTGS2—Metabolism—ALDOA—coronary artery disease	4.6e-06	0.00014	CbGpPWpGaD
Nabumetone—PTGS2—Disease—PSMA6—coronary artery disease	4.56e-06	0.000139	CbGpPWpGaD
Nabumetone—PTGS2—Disease—PSMB5—coronary artery disease	4.56e-06	0.000139	CbGpPWpGaD
Nabumetone—PTGS2—Metabolism—DCN—coronary artery disease	4.47e-06	0.000136	CbGpPWpGaD
Nabumetone—PTGS2—Disease—GOT2—coronary artery disease	4.41e-06	0.000135	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism—PLIN1—coronary artery disease	4.4e-06	0.000134	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism—COX5B—coronary artery disease	4.4e-06	0.000134	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism—GSTM2—coronary artery disease	4.4e-06	0.000134	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism—PFKFB3—coronary artery disease	4.4e-06	0.000134	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism—DLAT—coronary artery disease	4.4e-06	0.000134	CbGpPWpGaD
Nabumetone—PTGS2—Disease—CYBA—coronary artery disease	4.4e-06	0.000134	CbGpPWpGaD
Nabumetone—PTGS2—Disease—CALR—coronary artery disease	4.38e-06	0.000133	CbGpPWpGaD
Nabumetone—PTGS2—Metabolism—ALDH2—coronary artery disease	4.35e-06	0.000132	CbGpPWpGaD
Nabumetone—PTGS1—Metabolism—PLCB1—coronary artery disease	4.28e-06	0.00013	CbGpPWpGaD
Nabumetone—PTGS2—Metabolism of lipids and lipoproteins—PPARG—coronary artery disease	4.24e-06	0.000129	CbGpPWpGaD
Nabumetone—PTGS2—Metabolism—HBA1—coronary artery disease	4.24e-06	0.000129	CbGpPWpGaD
Nabumetone—PTGS2—Metabolism—LIPC—coronary artery disease	4.24e-06	0.000129	CbGpPWpGaD
Nabumetone—PTGS2—Metabolism—PIK3C2A—coronary artery disease	4.24e-06	0.000129	CbGpPWpGaD
Nabumetone—PTGS2—Metabolism—CYP2C19—coronary artery disease	4.24e-06	0.000129	CbGpPWpGaD
Nabumetone—PTGS2—Metabolism—APOC3—coronary artery disease	4.21e-06	0.000128	CbGpPWpGaD
Nabumetone—PTGS1—Metabolism of lipids and lipoproteins—PTGS2—coronary artery disease	4.2e-06	0.000128	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism of lipids and lipoproteins—ABCA1—coronary artery disease	4.19e-06	0.000128	CbGpPWpGaD
Nabumetone—PTGS2—Metabolism—LDLR—coronary artery disease	4.19e-06	0.000128	CbGpPWpGaD
Nabumetone—PTGS2—Metabolism of lipids and lipoproteins—POMC—coronary artery disease	4.18e-06	0.000127	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism—SULT1E1—coronary artery disease	4.18e-06	0.000127	CbGpPWpGaD
Nabumetone—PTGS1—Metabolism—ABCA1—coronary artery disease	4.15e-06	0.000126	CbGpPWpGaD
Nabumetone—PTGS2—Metabolism—GSTT1—coronary artery disease	4.14e-06	0.000126	CbGpPWpGaD
Nabumetone—PTGS2—Metabolism—SLC9A1—coronary artery disease	4.14e-06	0.000126	CbGpPWpGaD
Nabumetone—PTGS2—Metabolism—CETP—coronary artery disease	4.09e-06	0.000125	CbGpPWpGaD
Nabumetone—PTGS2—Metabolism—GCLC—coronary artery disease	4.09e-06	0.000125	CbGpPWpGaD
Nabumetone—PTGS2—Disease—JUNB—coronary artery disease	4.07e-06	0.000124	CbGpPWpGaD
Nabumetone—PTGS2—Disease—HSPA1A—coronary artery disease	4.07e-06	0.000124	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism of lipids and lipoproteins—GGT1—coronary artery disease	4.06e-06	0.000124	CbGpPWpGaD
Nabumetone—PTGS2—Metabolism—SDC1—coronary artery disease	4.04e-06	0.000123	CbGpPWpGaD
Nabumetone—PTGS1—Metabolism—GGT1—coronary artery disease	4.02e-06	0.000123	CbGpPWpGaD
Nabumetone—PTGS1—Metabolism—GOT1—coronary artery disease	4.02e-06	0.000123	CbGpPWpGaD
Nabumetone—PTGS2—Integrated Pancreatic Cancer Pathway—AKT1—coronary artery disease	4.01e-06	0.000122	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism—AKR1B1—coronary artery disease	3.98e-06	0.000121	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism—HK2—coronary artery disease	3.98e-06	0.000121	CbGpPWpGaD
Nabumetone—PTGS2—Metabolism—PSMA6—coronary artery disease	3.82e-06	0.000116	CbGpPWpGaD
Nabumetone—PTGS2—Metabolism—PSMB5—coronary artery disease	3.82e-06	0.000116	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism—SLC27A1—coronary artery disease	3.82e-06	0.000116	CbGpPWpGaD
Nabumetone—PTGS2—Metabolism of lipids and lipoproteins—ALB—coronary artery disease	3.81e-06	0.000116	CbGpPWpGaD
Nabumetone—PTGS2—Disease—GOT1—coronary artery disease	3.81e-06	0.000116	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism—CPT1B—coronary artery disease	3.74e-06	0.000114	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism—LCAT—coronary artery disease	3.74e-06	0.000114	CbGpPWpGaD
Nabumetone—PTGS2—Metabolism—CTGF—coronary artery disease	3.73e-06	0.000114	CbGpPWpGaD
Nabumetone—PTGS2—Metabolism—GOT2—coronary artery disease	3.7e-06	0.000113	CbGpPWpGaD
Nabumetone—PTGS2—Metabolism—HMGCR—coronary artery disease	3.7e-06	0.000113	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism—APOA4—coronary artery disease	3.68e-06	0.000112	CbGpPWpGaD
Nabumetone—PTGS1—Metabolism—GSTP1—coronary artery disease	3.61e-06	0.00011	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism of lipids and lipoproteins—PPARGC1A—coronary artery disease	3.61e-06	0.00011	CbGpPWpGaD
Nabumetone—PTGS1—Metabolism—PPARGC1A—coronary artery disease	3.58e-06	0.000109	CbGpPWpGaD
Nabumetone—PTGS1—Metabolism—HMOX1—coronary artery disease	3.56e-06	0.000109	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism—PDHA1—coronary artery disease	3.55e-06	0.000108	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism—GCLM—coronary artery disease	3.55e-06	0.000108	CbGpPWpGaD
Nabumetone—PTGS2—Disease—PRKCE—coronary artery disease	3.52e-06	0.000107	CbGpPWpGaD
Nabumetone—PTGS1—Metabolism—CAT—coronary artery disease	3.51e-06	0.000107	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism of lipids and lipoproteins—APOB—coronary artery disease	3.44e-06	0.000105	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism—TXNRD1—coronary artery disease	3.44e-06	0.000105	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism—CYP11B2—coronary artery disease	3.44e-06	0.000105	CbGpPWpGaD
Nabumetone—PTGS2—Disease—TGFBR2—coronary artery disease	3.42e-06	0.000104	CbGpPWpGaD
Nabumetone—PTGS2—Disease—KITLG—coronary artery disease	3.42e-06	0.000104	CbGpPWpGaD
Nabumetone—PTGS1—Metabolism—APOB—coronary artery disease	3.41e-06	0.000104	CbGpPWpGaD
Nabumetone—PTGS2—Metabolism—PLCB1—coronary artery disease	3.4e-06	0.000104	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism—SLC22A3—coronary artery disease	3.39e-06	0.000103	CbGpPWpGaD
Nabumetone—PTGS2—Disease—STAT5A—coronary artery disease	3.35e-06	0.000102	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism—HADH—coronary artery disease	3.34e-06	0.000102	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism—ARNTL—coronary artery disease	3.34e-06	0.000102	CbGpPWpGaD
Nabumetone—PTGS1—Metabolism—GSTM1—coronary artery disease	3.32e-06	0.000101	CbGpPWpGaD
Nabumetone—PTGS2—Metabolism—ABCA1—coronary artery disease	3.3e-06	0.0001	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism of lipids and lipoproteins—LPL—coronary artery disease	3.29e-06	0.0001	CbGpPWpGaD
Nabumetone—PTGS1—Metabolism—LPL—coronary artery disease	3.26e-06	9.93e-05	CbGpPWpGaD
Nabumetone—PTGS2—Disease—APOB—coronary artery disease	3.23e-06	9.85e-05	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism of lipids and lipoproteins—GPX1—coronary artery disease	3.21e-06	9.77e-05	CbGpPWpGaD
Nabumetone—PTGS2—Metabolism—GOT1—coronary artery disease	3.19e-06	9.73e-05	CbGpPWpGaD
Nabumetone—PTGS2—Metabolism—GGT1—coronary artery disease	3.19e-06	9.73e-05	CbGpPWpGaD
Nabumetone—PTGS1—Metabolism—GPX1—coronary artery disease	3.18e-06	9.68e-05	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism—PLA2G2A—coronary artery disease	3.16e-06	9.64e-05	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism—APOA2—coronary artery disease	3.16e-06	9.64e-05	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism—GPX2—coronary artery disease	3.16e-06	9.64e-05	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism—ABCG5—coronary artery disease	3.13e-06	9.52e-05	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism—GPX4—coronary artery disease	3.13e-06	9.52e-05	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism—SULT1A1—coronary artery disease	3.13e-06	9.52e-05	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism—HK1—coronary artery disease	3.13e-06	9.52e-05	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism of lipids and lipoproteins—CD36—coronary artery disease	3.12e-06	9.51e-05	CbGpPWpGaD
Nabumetone—PTGS2—Disease—FGF1—coronary artery disease	3.11e-06	9.48e-05	CbGpPWpGaD
Nabumetone—PTGS1—Metabolism—CD36—coronary artery disease	3.1e-06	9.43e-05	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism—HADHA—coronary artery disease	3.09e-06	9.41e-05	CbGpPWpGaD
Nabumetone—PTGS2—Disease—LPL—coronary artery disease	3.09e-06	9.41e-05	CbGpPWpGaD
Nabumetone—PTGS1—Metabolism—PPP2CA—coronary artery disease	3.06e-06	9.31e-05	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism—GSTA1—coronary artery disease	3.05e-06	9.3e-05	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism—LPA—coronary artery disease	3.02e-06	9.2e-05	CbGpPWpGaD
Nabumetone—PTGS1—Metabolism—MTHFR—coronary artery disease	2.93e-06	8.94e-05	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism—PLCB3—coronary artery disease	2.92e-06	8.91e-05	CbGpPWpGaD
Nabumetone—PTGS2—Disease—PPP2CA—coronary artery disease	2.9e-06	8.83e-05	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism—APOA5—coronary artery disease	2.89e-06	8.82e-05	CbGpPWpGaD
Nabumetone—PTGS2—Metabolism—GSTP1—coronary artery disease	2.87e-06	8.74e-05	CbGpPWpGaD
Nabumetone—PTGS2—Disease—PRKCD—coronary artery disease	2.84e-06	8.67e-05	CbGpPWpGaD
Nabumetone—PTGS2—Metabolism—PPARGC1A—coronary artery disease	2.84e-06	8.65e-05	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism—P4HB—coronary artery disease	2.84e-06	8.65e-05	CbGpPWpGaD
Nabumetone—PTGS2—Metabolism—HMOX1—coronary artery disease	2.83e-06	8.62e-05	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism of lipids and lipoproteins—AGT—coronary artery disease	2.81e-06	8.57e-05	CbGpPWpGaD
Nabumetone—PTGS2—Metabolism—CAT—coronary artery disease	2.79e-06	8.5e-05	CbGpPWpGaD
Nabumetone—PTGS1—Metabolism—AGT—coronary artery disease	2.79e-06	8.49e-05	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism—PLA2G1B—coronary artery disease	2.79e-06	8.49e-05	CbGpPWpGaD
Nabumetone—PTGS2—Disease—MTHFR—coronary artery disease	2.78e-06	8.47e-05	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism of lipids and lipoproteins—APOE—coronary artery disease	2.75e-06	8.39e-05	CbGpPWpGaD
Nabumetone—PTGS1—Metabolism—APOE—coronary artery disease	2.73e-06	8.32e-05	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism of lipids and lipoproteins—APOA1—coronary artery disease	2.72e-06	8.3e-05	CbGpPWpGaD
Nabumetone—PTGS2—Metabolism—APOB—coronary artery disease	2.71e-06	8.25e-05	CbGpPWpGaD
Nabumetone—PTGS1—Metabolism—APOA1—coronary artery disease	2.7e-06	8.22e-05	CbGpPWpGaD
Nabumetone—PTGS2—Disease—HIF1A—coronary artery disease	2.65e-06	8.08e-05	CbGpPWpGaD
Nabumetone—PTGS2—Metabolism—GSTM1—coronary artery disease	2.63e-06	8.03e-05	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism—VCAN—coronary artery disease	2.63e-06	8e-05	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism—ALDOA—coronary artery disease	2.61e-06	7.94e-05	CbGpPWpGaD
Nabumetone—PTGS2—Disease—APOE—coronary artery disease	2.59e-06	7.89e-05	CbGpPWpGaD
Nabumetone—PTGS2—Metabolism—LPL—coronary artery disease	2.59e-06	7.88e-05	CbGpPWpGaD
Nabumetone—PTGS1—Metabolism of lipids and lipoproteins—PIK3CA—coronary artery disease	2.58e-06	7.88e-05	CbGpPWpGaD
Nabumetone—PTGS2—Disease—APOA1—coronary artery disease	2.56e-06	7.8e-05	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism—DCN—coronary artery disease	2.53e-06	7.71e-05	CbGpPWpGaD
Nabumetone—PTGS2—Metabolism—GPX1—coronary artery disease	2.52e-06	7.69e-05	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism—ALDH2—coronary artery disease	2.46e-06	7.5e-05	CbGpPWpGaD
Nabumetone—PTGS2—Metabolism—CD36—coronary artery disease	2.46e-06	7.49e-05	CbGpPWpGaD
Nabumetone—PTGS2—Disease—IL6ST—coronary artery disease	2.43e-06	7.41e-05	CbGpPWpGaD
Nabumetone—PTGS2—Metabolism—PPP2CA—coronary artery disease	2.43e-06	7.39e-05	CbGpPWpGaD
Nabumetone—PTGS2—Disease—NOS2—coronary artery disease	2.41e-06	7.35e-05	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—coronary artery disease	2.4e-06	7.31e-05	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism—LIPC—coronary artery disease	2.4e-06	7.31e-05	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism—HBA1—coronary artery disease	2.4e-06	7.31e-05	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism—PIK3C2A—coronary artery disease	2.4e-06	7.31e-05	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism—CYP2C19—coronary artery disease	2.4e-06	7.31e-05	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism—APOC3—coronary artery disease	2.38e-06	7.26e-05	CbGpPWpGaD
Nabumetone—PTGS1—Metabolism—PPARG—coronary artery disease	2.38e-06	7.25e-05	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism—LDLR—coronary artery disease	2.37e-06	7.22e-05	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism of lipids and lipoproteins—POMC—coronary artery disease	2.37e-06	7.21e-05	CbGpPWpGaD
Nabumetone—PTGS1—Metabolism—POMC—coronary artery disease	2.35e-06	7.15e-05	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism—GSTT1—coronary artery disease	2.34e-06	7.13e-05	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism—SLC9A1—coronary artery disease	2.34e-06	7.13e-05	CbGpPWpGaD
Nabumetone—PTGS2—Disease—KIT—coronary artery disease	2.34e-06	7.12e-05	CbGpPWpGaD
Nabumetone—PTGS2—Metabolism—MTHFR—coronary artery disease	2.33e-06	7.09e-05	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism—CETP—coronary artery disease	2.31e-06	7.05e-05	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism—GCLC—coronary artery disease	2.31e-06	7.05e-05	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism—SDC1—coronary artery disease	2.29e-06	6.97e-05	CbGpPWpGaD
Nabumetone—PTGS2—Disease—GSK3B—coronary artery disease	2.24e-06	6.83e-05	CbGpPWpGaD
Nabumetone—PTGS2—Disease—CREB1—coronary artery disease	2.22e-06	6.78e-05	CbGpPWpGaD
Nabumetone—PTGS2—Metabolism—AGT—coronary artery disease	2.21e-06	6.74e-05	CbGpPWpGaD
Nabumetone—PTGS2—Disease—IL6R—coronary artery disease	2.17e-06	6.61e-05	CbGpPWpGaD
Nabumetone—PTGS2—Metabolism—APOE—coronary artery disease	2.17e-06	6.6e-05	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism—PSMB5—coronary artery disease	2.16e-06	6.59e-05	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism—PSMA6—coronary artery disease	2.16e-06	6.59e-05	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism of lipids and lipoproteins—ALB—coronary artery disease	2.16e-06	6.57e-05	CbGpPWpGaD
Nabumetone—PTGS2—Metabolism—APOA1—coronary artery disease	2.14e-06	6.53e-05	CbGpPWpGaD
Nabumetone—PTGS1—Metabolism—ALB—coronary artery disease	2.14e-06	6.52e-05	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism—CTGF—coronary artery disease	2.11e-06	6.43e-05	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism—GOT2—coronary artery disease	2.09e-06	6.38e-05	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism—HMGCR—coronary artery disease	2.09e-06	6.38e-05	CbGpPWpGaD
Nabumetone—PTGS2—Metabolism of lipids and lipoproteins—PIK3CA—coronary artery disease	2.05e-06	6.25e-05	CbGpPWpGaD
Nabumetone—PTGS1—Metabolism—NOS3—coronary artery disease	2.05e-06	6.23e-05	CbGpPWpGaD
Nabumetone—PTGS2—Disease—SERPINE1—coronary artery disease	2.03e-06	6.19e-05	CbGpPWpGaD
Nabumetone—PTGS2—Disease—FGF2—coronary artery disease	1.97e-06	5.99e-05	CbGpPWpGaD
Nabumetone—PTGS2—Disease—NOS3—coronary artery disease	1.94e-06	5.91e-05	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism—PLCB1—coronary artery disease	1.92e-06	5.86e-05	CbGpPWpGaD
Nabumetone—PTGS2—Metabolism—PPARG—coronary artery disease	1.89e-06	5.75e-05	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—coronary artery disease	1.89e-06	5.75e-05	CbGpPWpGaD
Nabumetone—PTGS2—Disease—JAK2—coronary artery disease	1.88e-06	5.74e-05	CbGpPWpGaD
Nabumetone—PTGS1—Metabolism—PTGS2—coronary artery disease	1.87e-06	5.7e-05	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism—ABCA1—coronary artery disease	1.86e-06	5.68e-05	CbGpPWpGaD
Nabumetone—PTGS2—Metabolism—POMC—coronary artery disease	1.86e-06	5.67e-05	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism—GGT1—coronary artery disease	1.81e-06	5.5e-05	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism—GOT1—coronary artery disease	1.81e-06	5.5e-05	CbGpPWpGaD
Nabumetone—PTGS2—Metabolism—ALB—coronary artery disease	1.7e-06	5.17e-05	CbGpPWpGaD
Nabumetone—PTGS2—Metabolism—NOS3—coronary artery disease	1.62e-06	4.95e-05	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism—GSTP1—coronary artery disease	1.62e-06	4.94e-05	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism—PPARGC1A—coronary artery disease	1.61e-06	4.9e-05	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism—HMOX1—coronary artery disease	1.6e-06	4.88e-05	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism—CAT—coronary artery disease	1.58e-06	4.81e-05	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism—APOB—coronary artery disease	1.53e-06	4.67e-05	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism—GSTM1—coronary artery disease	1.49e-06	4.54e-05	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism—LPL—coronary artery disease	1.46e-06	4.46e-05	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism—GPX1—coronary artery disease	1.43e-06	4.35e-05	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism—CD36—coronary artery disease	1.39e-06	4.24e-05	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism—PPP2CA—coronary artery disease	1.37e-06	4.18e-05	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism—MTHFR—coronary artery disease	1.32e-06	4.01e-05	CbGpPWpGaD
Nabumetone—PTGS2—Disease—TGFB1—coronary artery disease	1.28e-06	3.91e-05	CbGpPWpGaD
Nabumetone—PTGS2—Disease—MAPK1—coronary artery disease	1.26e-06	3.83e-05	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism—AGT—coronary artery disease	1.25e-06	3.81e-05	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism—APOE—coronary artery disease	1.23e-06	3.74e-05	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism—APOA1—coronary artery disease	1.21e-06	3.69e-05	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—coronary artery disease	1.16e-06	3.54e-05	CbGpPWpGaD
Nabumetone—PTGS1—Metabolism—PIK3CA—coronary artery disease	1.15e-06	3.51e-05	CbGpPWpGaD
Nabumetone—PTGS2—Disease—PIK3CA—coronary artery disease	1.09e-06	3.32e-05	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism—PPARG—coronary artery disease	1.07e-06	3.26e-05	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism—POMC—coronary artery disease	1.05e-06	3.21e-05	CbGpPWpGaD
Nabumetone—PTGS2—Disease—IL6—coronary artery disease	9.66e-07	2.94e-05	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism—ALB—coronary artery disease	9.61e-07	2.93e-05	CbGpPWpGaD
Nabumetone—PTGS1—Metabolism—AKT1—coronary artery disease	9.4e-07	2.87e-05	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism—NOS3—coronary artery disease	9.19e-07	2.8e-05	CbGpPWpGaD
Nabumetone—PTGS2—Metabolism—PIK3CA—coronary artery disease	9.14e-07	2.78e-05	CbGpPWpGaD
Nabumetone—PTGS2—Disease—AKT1—coronary artery disease	8.91e-07	2.72e-05	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism—PTGS2—coronary artery disease	8.4e-07	2.56e-05	CbGpPWpGaD
Nabumetone—PTGS2—Metabolism—AKT1—coronary artery disease	7.46e-07	2.27e-05	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism—PIK3CA—coronary artery disease	5.17e-07	1.58e-05	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism—AKT1—coronary artery disease	4.22e-07	1.29e-05	CbGpPWpGaD
